First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...

A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic ...

A new study by researchers at Brigham and Women's Hospital in collaboration with researchers at Harvard T.H. Chan School of ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...

Meds like Wegovy are all over the news. But are they right for you, especially if you're older than the average user?By Are ...

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

“We know that generally, with and without obesity, mental health and suicidality is ... who has done similar work analyzing ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are ...

Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42 ...